Pathological tau: a loss of normal function or a gain in toxicity?
- 1 September 2005
- journal article
- editorial
- Published by Springer Nature in Nature Neuroscience
- Vol. 8 (9) , 1136-1137
- https://doi.org/10.1038/nn0905-1136
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Introduction: Advancing Drug Discovery for Alzheimers Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimers Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]Current Alzheimer Research, 2005
- β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing AgentsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy modelProceedings of the National Academy of Sciences, 2004
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughsNature Medicine, 2004
- Back to the future: the 'old-fashioned' way to new medications for neurodegenerationNature Medicine, 2004
- Protein folding and misfoldingNature, 2003
- Novel Method to Quantify Neuropil Threads in Brains from Elders With or Without Cognitive ImpairmentJournal of Histochemistry & Cytochemistry, 2000
- The disordered neuronal cytoskeleton in Alzheimer's diseaseCurrent Opinion in Neurobiology, 1992